Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China
Keyword(s):
Keyword(s):
1996 ◽
Vol 5
(1)
◽
pp. 31-35
Keyword(s):
Keyword(s):
2021 ◽
Keyword(s):
1996 ◽
Vol 5
(1)
◽
pp. 31-35
◽
Keyword(s):
2020 ◽
2020 ◽
Keyword(s):
Keyword(s):